Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
you are here: HomeNewsBusiness

'Dr Reddy's expects Sputnik V vaccine to get approval from Indian regulator in next few weeks'

It is a two-dose vaccine. You take the first dose on day zero and the second one on day 21. The peak immunity develops somewhere between day 28 to day 42. So, it is a two-dose vaccine and we expect it to be available in the next few weeks,” Deepak Sapra, the company's CEO, APIs and Services, said.

March 29, 2021 / 01:20 PM IST
Sputnik V is priced at less than $10 per shot, making it one of the most affordable vaccines. (Image: Reuters)

Sputnik V is priced at less than $10 per shot, making it one of the most affordable vaccines. (Image: Reuters)

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Pharma major Dr Reddy’s Laboratories expects the Russian coronavirus vaccine Sputnik V to get approval from the Indian regulator in the next few weeks, a company official has said. ”We expect to get the approval in the next few weeks.

It is a two-dose vaccine. You take the first dose on day zero and the second one on day 21. The peak immunity develops somewhere between day 28 to day 42. So, it is a two-dose vaccine and we expect it to be available in the next few weeks,” Deepak Sapra, the company's CEO, APIs and Services, said.

Sapra, who was speaking in a webinar on Sunday evening, was asked as to how soon Sputnik would be available and whether it is a one dose or two doses vaccine.

Dr Reddy’s has partnered with the Russia Direct Investment Fund (RDIF) to bring the Sputnik V vaccine to India and other countries, he said. Observing that trials of the vaccine have been conducted in Russia, India, the UAE and others, he said the vaccine demonstrated an efficacy of 91.6 percent as published in reputed journal Lancet.